Deijen CL, Vasmel JE, de Lange-de Klerk ESM et al (2017) Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer. Surg Endosc 31:2607–2615

Article  Google Scholar 

Bertelsen CA, Neuenschwander AU, Jansen JE et al (2015) Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol 16:161–168

Article  Google Scholar 

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403

Article  CAS  Google Scholar 

Gray R, Barnwell J, McConkey C et al (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 370:2020–2029

Article  Google Scholar 

Benson AB, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408–3419

Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited--the role of tumour-stroma interactions in metastasis to different organs. Int J Cancer 128:2527–2535

Article  CAS  Google Scholar 

De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429–447

Article  Google Scholar 

Quail DF, Joyce JA (2013) Microenvironmental regulation of tumour progression and metastasis. Nat Med 19:1423–1437

Article  CAS  Google Scholar 

Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumour stroma. Exp Cell Res 316:1324–1331

Article  CAS  Google Scholar 

Mesker WE, Junggeburt JM, Szuhai K et al (2007) The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumour stage. Cell Oncol 29:387–398

PubMed  PubMed Central  Google Scholar 

Park JH, Richards CH, McMillan DC (2014) The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol 25:644–651

Article  CAS  Google Scholar 

Huijbers A, Tollenaar RA (2013) V Pelt GW, et al. the proportion of tumour-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 24:179–185

Article  CAS  Google Scholar 

Mesker WE, Liefers GJ, Junggeburt JM et al (2009) Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol 31:169–178

CAS  PubMed  PubMed Central  Google Scholar 

Zengin M (2019) Prognostic role of tumor-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: a broad methodological study in a fairly homogeneous population. Ann Diagn Pathol 41:69–78

Article  Google Scholar 

Zengin M (2020) Local inflammatory response can predict clinical outcome in patients with curatively resected stage-IIB Colon Cancer: an advanced methodological study. Pathol Oncol Res 26:1805-1816

McShane LM, Altman DG, Sauerbrei W et al (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:387–391

Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the International Union against Cancer and the American joint committee on Cancer. Cancer. 116(22):5336–5339

Eriksen AC, Sørensen FB, Lindebjerg J et al (2018) The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study. Int J Color Dis 33(8):1115–1124

Salgado R, Denkert C, Demaria S et al (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol 26:259–271

Article  CAS  Google Scholar 

McGraw KO (1996) Forming inferences about some intraclass correlation coefficient. Psychol Methods 1:30–46

Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. 33:159–174

West NP, Dattani M, McShane P et al (2020) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102(10):1519–1523

Hutchins GGA, Treanor D, Wright A et al (2017) Intra-tumoural stromal morphometry predicts disease recurrence but no a response to 5-fluorouracil—results from the QUASAR trial of colorectal cancer. Histopathology 3:391–404

Hynes SO, Coleman HG, Kelly PJ et al (2017) Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study. Histopathology. 71:12–26

van Pelt GW, Hansen TB, Esther B et al (2016) Stroma-high lymph node involvement predicts poor survival more accurately for patients with stage III colon cancer. J Med Surg Pathol 1:116

Moserle L, Casanovas O (2013) Anti-angiogenesis and metastasis: a tumour and stromal cell alliance. J Intern Med 273:128–137

Article  CAS  Google Scholar 

Koukourakis MI, Giatromanolaki A, Harris AL et al (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:632–637

Article  CAS  Google Scholar 

Guthrie GJ, Roxburgh CS, Richards CH et al (2013) Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer 109:131–137

Article  CAS  Google Scholar 

Ueno H, Jones AM, Wilkinson KH et al (2004) Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut. 53:581–586

Article  CAS  Google Scholar 

Lieubeau B, Heymann MF, Henry F et al (1999) Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 81:629–636

Article  CAS  Google Scholar 

Hemmings C (2013) Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis. Pathology (Phila) 45:371–381

Google Scholar 

Tsujino T, Seshimo I, Yamamoto H et al (2007) Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 13:2082–2090

Article  CAS  Google Scholar